Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (61,276)	$ (1,866)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	14,251	13,476
Amortization of intangible assets	17,772	13,552
Reduction in carrying amount of right-of-use asset	8,477
Provision for doubtful accounts	626	861
Share-based compensation	19,792	15,525
Deferred income taxes	801	(6,516)
Non-cash restructuring and impairment charges	7,622
Unrealized/realized gain on equity investment		274
Non-cash interest expense	1,982	1,532
Other	735	(344)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	25,751	66,568
Inventories	3,157	5,570
Prepaid expenses and other assets	(274)	(12,390)
Accounts payable	(9,070)	(40,050)
Accrued compensation and benefits	(3,036)	(3,851)
Operating lease liabilities	(9,051)
Deferred revenue	6,181	11,568
Other current and long-term liabilities	(2,529)	(2,298)
Net cash provided by operating activities	21,911	61,611
Cash flows from investing activities:
Capital expenditures	(9,438)	(11,140)
Business acquisitions, net of cash acquired	(219,458)
Maturities and sales of investments	45,249	727
Net cash used in investing activities	(183,647)	(10,413)
Cash flows from financing activities:
Borrowings under Term Loan	199,500
Repayments of debt	(24,950)	(14,933)
Loan fees on borrowings	(10,514)	(545)
Equity forward contract	(4,821)
Repurchase of common stock	(25,179)	(15,000)
Proceeds from issuance of common stock, net of tax withholding	2,906	5,005
Payment of contingent consideration obligations	(2,000)	(3,856)
Deferred payments on an acquisition	(2,206)	(2,000)
Net cash provided by (used in) financing activities	132,736	(31,329)
Foreign currency effect on cash	(193)	(365)
Net (decrease) increase in cash	(29,193)	19,504
Cash at beginning of period	169,607	121,139
Cash at end of period	$ 140,414	$ 140,643